Brian G. Choi

Brian G. Choi

Auto-generated profile, based on publicly available information

Brian G. Choi

The George Washington University School of Medicine and Health Sciences, Washington, DC

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
GVG. Vilahur
G. Vilahur
BCB. G. Choi
B. G. Choi
MZM. U. Zafar
M. U. Zafar
JVJ. F. Viles‐Gonzalez
J. F. Viles‐Gonzalez
DVD. A. Vorchheimer
D. A. Vorchheimer
Juan J. BadimonJuan J. Badimon
Juan J. Badimon

1 March 2008 in JACC
Verified
Journal Article
Closed access
BIBorja Ibanez
Borja Ibanez
GVGemma Vilahur
Gemma Vilahur
GCGiovanni Cimmino
Giovanni Cimmino
WSWalter S. Speidl
Walter S. Speidl
APAntonio Pinero
Antonio Pinero
JBJuan J. Badimon
Juan J. Badimon

1 December 2011 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
BCBrian G. Choi
Brian G. Choi
MMMonica Mukherjee
Monica Mukherjee
PDPraveen Dala
Praveen Dala
HYHeather A. Young
Heather A. Young
CTCynthia M. Tracy
Cynthia M. Tracy
JLJannet F. Lewis
Jannet F. Lewis

1 June 2007 in Endocrinology and Metabolism Clinics of North America
Verified
Journal Article
Closed access
BCBrian G. Choi
Brian G. Choi
MMMary Ann McLaughlin
Mary Ann McLaughlin

1 August 2006 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
BCB. G. Choi
B. G. Choi
GVG. Vilahur
G. Vilahur
DYD. Yadegar
D. Yadegar
JVJ. F. Viles-Gonzalez
J. F. Viles-Gonzalez
JBJ. J. Badimon
J. J. Badimon
Despite significant progress in the management of atherosclerosis and its resultant complications, cardiovascular disease remains the principal cause of death in the world. The National Cholesterol Education Project Adult Treatment Panel III (NCEP ATP III) recognizes low levels of highdensity lipoprotein cholesterol (HDL) as a risk factor for coronary heart disease (CHD) and high levels of HDL as a risk-reducing factor; however, the elevation of HDL as a specific therapeutic target for the prevention and treatment of CHD has yet to be accepted on the same level as low-density lipoprotein (LDL)-reducing therapies. Current HDL elevators including nicotinic acid, fibric acid derivatives, peroxisome proliferator activated receptor (PPAR) agonists and statins also affect other lipid constituents which make interpretation of the clinical trials of these drugs difficult in teasing out the independent effect of HDL elevation. Ample laboratory investigation suggests that HDL elevation would reduce atherosclerotic burden through multiple independent mechanisms. In this review, we explore HDL biology, its potential mechanisms in the treatment of atherosclerotic disease, and promising new drugs with HDL-raising activity.

23 April 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
BCBrian G Choi
Brian G Choi
TDTania Dhawan
Tania Dhawan
KMKelli Metzger
Kelli Metzger
LMLorraine Marshall
Lorraine Marshall
AAAwdah Akbar
Awdah Akbar
RKRichard J Katz
Richard J Katz
Background: Randomized controlled trials conducted in Mediterranean countries have shown that the Mediterranean diet lowers adverse cardiovascular events. In the American population, diet remains the biggest uncontrolled risk factor for cardiovascular disease. Objective: This study aimed to test the hypothesis that asynchronous dietary counseling supplied through a custom smartphone app results in better adherence to a Mediterranean diet in a non-Mediterranean population than traditional standard-of-care (SOC) counseling. Methods: In total, 100 patients presenting to the cardiology clinic of an academic medical center were randomized to either the SOC or smartphone app-based experimental (EXP) Mediterranean diet intervention after informed consent and 1 hour of individual face-to-face dietary counseling with a registered dietitian. Participants in EXP received a custom smartphone app that reinforced the Mediterranean diet, whereas participants in SOC received 2 additional sessions of in-person dietary counseling with the registered dietitian—30 min at 1 month and 30 min at 3 months. Preexisting knowledge of a Mediterranean diet was measured by the validated Mediterranean Diet Score (MDS) instrument. Baseline height, weight, blood pressure (BP), and laboratory biomarkers were collected. At 1, 3, and 6 months, participants presented for a follow-up appointment to assess compliance to the Mediterranean diet using the MDS as well as a patient satisfaction survey, BP, and weight. Repeat laboratory biomarkers were performed at 3 and 6 months. Results: Enrolled participants had a mean age with SE of 56.6 (SD 1.7) for SOC and 57.2 (SD 1.8) for EXP; 65.3% of SOC and 56.9% of EXP were male, and 20.4% of SOC and 35.3% of EXP had coronary artery disease. There were no significant differences between EXP and SOC with regard to BP, lipid parameters, hemoglobin A1c, or C-reactive protein (CRP). Participants in EXP achieved a significantly greater weight loss on average of 3.3 pounds versus 3.1 pounds for participants in SOC, P=.04. Adherence to the Mediterranean diet increased significantly over time for both groups (P<.001), but there was no significant difference between groups (P=.69). Similarly, there was no significant difference in diet satisfaction between EXP and SOC, although diet satisfaction increased significantly over time for both groups. The proportion of participants with high Mediterranean diet compliance (defined as the MDS ≥9) increased significantly over time (P<.001)—from 18.4% to 57.1% for SOC and 27.5% to 64.7% for EXP; however, there was no significant difference between the groups. Conclusions: Both traditional SOC counseling and smartphone-based counseling were effective in getting participants to adhere to a Mediterranean diet, and these dietary changes persisted even after counseling had ended. However, neither method was more effective than the other. This pilot study demonstrates that patients can change to and maintain a Mediterranean diet with either traditional or smartphone app-based nutrition counseling. Trial Registration: ClinicalTrials.gov NCT03897426;https://clinicaltrials.gov/ct2/show/NCT03897426